REGENERON PHARMACEUTICALS, INC. Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10
REGENERON PHARMACEUTICALS, INC. (REGN) had Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10 of $15.00 million as of 2017-03-31, per its 10-Q filed 2017-05-04.
Discontinued › Notes › Investments › Debt Securities, Available-for-Sale, Maturity, Allocated and Single Maturity Date, Fair Value
us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue · last filed 2017-05-04
- 2017-03-31: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10 $15.00M.
- 2016-12-31: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10 $0.00.
- 2015-12-31: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10 $0.00.
- 2015-09-30: Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10 $0.00.
| Period end | Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10 |
|---|---|
| 2017-03-31 | $15.00M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $0.00 10-Q · filed 2017-05-04 |
| 2015-12-31 | $0.00 10-K · filed 2016-02-11 |
| 2015-09-30 | $0.00 10-Q · filed 2015-11-04 |
| 2015-06-30 | $1.10M 10-Q · filed 2015-08-04 |
| 2015-03-31 | $1.10M 10-Q · filed 2015-05-07 |
| 2014-12-31 | $1.13M 10-K · filed 2016-02-11 |
| 2014-09-30 | $5.12M 10-Q · filed 2014-11-04 |
| 2014-06-30 | $4.04M 10-Q · filed 2014-08-05 |
| 2014-03-31 | $4.04M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $4.14M 10-K · filed 2015-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 |